BioCentury | Jul 30, 2015
Strategy

Neglected Attention

...Fund, undisclosed remainder from DNDi April 2014 PDE4NDP (PhosphoDiEsterase inhibitors for Neglected Parasitic Diseases) project Iota Pharmaceuticals Ltd....
BioCentury | May 22, 2014
Translation in Brief

Translational tidbits

...PROTHEVIH project to develop HIV vaccine VAC-3S, companion diagnostic test CO-3S and prognostic test DIAG-3S Iota Pharmaceuticals Ltd....
BioCentury | Apr 14, 2014
Company News

Iota Pharmaceuticals, Top Institute Pharma, European Screening Port, Fundacao Oswaldo Cruz, Spanish National Research Council, Theodore Bilharz Research Institu

...to conduct human clinical trials. The partners will share "benefits and revenues" of shared IP. IOTA Pharmaceuticals Ltd....
BioCentury | Aug 24, 2009
Company News

IOTA Pharmaceuticals Ltd., Mercachem B.V., Nycomed Group A/S, Drugs for Neglected Diseases initiative, Royal Tropical Institute, TI Pharma, University of Bern,

...total budget of €3.6 million ($5.1 million) over four years. Further terms were not disclosed. IOTA Pharmaceuticals Ltd....
BioCentury | Jun 22, 2009
Emerging Company Profile

More Efficient Resonance: Sidebar: Corporate Profile

...of Amsterdam Corporate partners: Cubist Pharmaceuticals Inc. , General Electric Co. , AstraZeneca plc , Iota Pharmaceuticals Ltd....
BioCentury | Apr 28, 2008
Company News

Beactica, Iota Pharmaceuticals Ltd. deal

...discovery partnerships with pharma companies. Further terms were not disclosed. Beactica AB , Uppsala, Sweden Iota Pharmaceuticals Ltd....
BioCentury | Oct 1, 2007
Company News

Iota Pharmaceuticals Ltd. chemistry, supply/service news

...at the VU University in Amsterdam by Iwan de Esch, Iota's head of drug discovery. Iota Pharmaceuticals Ltd....
Items per page:
1 - 7 of 7
BioCentury | Jul 30, 2015
Strategy

Neglected Attention

...Fund, undisclosed remainder from DNDi April 2014 PDE4NDP (PhosphoDiEsterase inhibitors for Neglected Parasitic Diseases) project Iota Pharmaceuticals Ltd....
BioCentury | May 22, 2014
Translation in Brief

Translational tidbits

...PROTHEVIH project to develop HIV vaccine VAC-3S, companion diagnostic test CO-3S and prognostic test DIAG-3S Iota Pharmaceuticals Ltd....
BioCentury | Apr 14, 2014
Company News

Iota Pharmaceuticals, Top Institute Pharma, European Screening Port, Fundacao Oswaldo Cruz, Spanish National Research Council, Theodore Bilharz Research Institu

...to conduct human clinical trials. The partners will share "benefits and revenues" of shared IP. IOTA Pharmaceuticals Ltd....
BioCentury | Aug 24, 2009
Company News

IOTA Pharmaceuticals Ltd., Mercachem B.V., Nycomed Group A/S, Drugs for Neglected Diseases initiative, Royal Tropical Institute, TI Pharma, University of Bern,

...total budget of €3.6 million ($5.1 million) over four years. Further terms were not disclosed. IOTA Pharmaceuticals Ltd....
BioCentury | Jun 22, 2009
Emerging Company Profile

More Efficient Resonance: Sidebar: Corporate Profile

...of Amsterdam Corporate partners: Cubist Pharmaceuticals Inc. , General Electric Co. , AstraZeneca plc , Iota Pharmaceuticals Ltd....
BioCentury | Apr 28, 2008
Company News

Beactica, Iota Pharmaceuticals Ltd. deal

...discovery partnerships with pharma companies. Further terms were not disclosed. Beactica AB , Uppsala, Sweden Iota Pharmaceuticals Ltd....
BioCentury | Oct 1, 2007
Company News

Iota Pharmaceuticals Ltd. chemistry, supply/service news

...at the VU University in Amsterdam by Iwan de Esch, Iota's head of drug discovery. Iota Pharmaceuticals Ltd....
Items per page:
1 - 7 of 7